No Supportive Evidence For The Use Of Multiple Long-Acting Antipsychotic Therapies In Patients With Schizophrenia
Does anyone use multiple LAI medications on one patient?
Although over a third of patients with schizophrenia in the United States receive 2 or more antipsychotic medications, no combination of antipsychotic drugs has ever been approved by the US Food and Drug Administration (FDA) based on controlled clinical trials. A search of the medical literature revealed no supportive evidence for use of multiple long-acting antipsychotic therapies in patients with schizophrenia. Augmentation with multiple antipsychotics is much debated, with unclear evidence for …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.